Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
Antimicrobial Agents and Chemotherapy
|
November 14, 2022
Targeting Artemisinin-Resistant Malaria by Repurposing the Anti-Hepatitis C Virus Drug Alisporivir
Ayushi Chaurasiya, Geeta Kumari, Swati Garg, et al.
Nature Communications
|
March 16, 2023
Clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinoma
Ainhoa Madariaga, Swati Garg, Nairi Tchrakian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2018
A Clinical and Molecular Phase II Trial of Oral ENMD-2076 in Ovarian Clear Cell Carcinoma (OCCC): A Study of the Princess Margaret Phase II Consortium
Stephanie Lheureux, Anna Tinker, Blaise Clarke, et al.
Cell Death Discovery
|
January 14, 2021
Pathogen induced subversion of NAD<sup>+</sup> metabolism mediating host cell death: a target for development of chemotherapeutics
Ayushi Chaurasiya, Swati Garg, Ashish Khanna, et al.
British Journal of Cancer
|
June 5, 2021
Essential role of the histone lysine demethylase KDM4A in the biology of malignant pleural mesothelioma (MPM)
Moshe Lapidot, Abigail E Case, Ellen L Weisberg, et al.
Blood
|
May 12, 2019
Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML
Swati Garg, Armando Reyes-Palomares, Lixiazi He, et al.
EMBO Molecular Medicine
|
March 7, 2022
CDK7/12/13 inhibition targets an oscillating leukemia stem cell network and synergizes with venetoclax in acute myeloid leukemia
Lixiazi He, Christian Arnold, Judith Thoma, et al.
Cancer Research Communications
|
March 6, 2023
Repurposing Itraconazole and Hydroxychloroquine to Target Lysosomal Homeostasis in Epithelial Ovarian Cancer
Stefano Marastoni, Ainhoa Madariaga, Aleksandra Pesic, et al.
Journal of Human Immunity
|
May 22, 2026
Mendelian susceptibility to mycobacterial disease: Clinical, immunological, and genetic study in India
Aparna Dalvi, Lavina Temkar, Mukesh Desai, et al.
Blood Cancer Journal
|
July 19, 2022
BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma
Ellen Weisberg, Basudev Chowdhury, Chengcheng Meng, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
Antimicrobial Agents and Chemotherapy
|
November 14, 2022
Targeting Artemisinin-Resistant Malaria by Repurposing the Anti-Hepatitis C Virus Drug Alisporivir
Ayushi Chaurasiya, Geeta Kumari, Swati Garg, et al.
Nature Communications
|
March 16, 2023
Clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinoma
Ainhoa Madariaga, Swati Garg, Nairi Tchrakian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2018
A Clinical and Molecular Phase II Trial of Oral ENMD-2076 in Ovarian Clear Cell Carcinoma (OCCC): A Study of the Princess Margaret Phase II Consortium
Stephanie Lheureux, Anna Tinker, Blaise Clarke, et al.
Cell Death Discovery
|
January 14, 2021
Pathogen induced subversion of NAD<sup>+</sup> metabolism mediating host cell death: a target for development of chemotherapeutics
Ayushi Chaurasiya, Swati Garg, Ashish Khanna, et al.
British Journal of Cancer
|
June 5, 2021
Essential role of the histone lysine demethylase KDM4A in the biology of malignant pleural mesothelioma (MPM)
Moshe Lapidot, Abigail E Case, Ellen L Weisberg, et al.
Blood
|
May 12, 2019
Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML
Swati Garg, Armando Reyes-Palomares, Lixiazi He, et al.
EMBO Molecular Medicine
|
March 7, 2022
CDK7/12/13 inhibition targets an oscillating leukemia stem cell network and synergizes with venetoclax in acute myeloid leukemia
Lixiazi He, Christian Arnold, Judith Thoma, et al.
Cancer Research Communications
|
March 6, 2023
Repurposing Itraconazole and Hydroxychloroquine to Target Lysosomal Homeostasis in Epithelial Ovarian Cancer
Stefano Marastoni, Ainhoa Madariaga, Aleksandra Pesic, et al.
Journal of Human Immunity
|
May 22, 2026
Mendelian susceptibility to mycobacterial disease: Clinical, immunological, and genetic study in India
Aparna Dalvi, Lavina Temkar, Mukesh Desai, et al.
Blood Cancer Journal
|
July 19, 2022
BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma
Ellen Weisberg, Basudev Chowdhury, Chengcheng Meng, et al.
Page
of 10